MAFA
EW icon

MJT & Associates Financial Advisory’s Edwards Lifesciences EW Stock Holding History

MJT & Associates Financial Advisory’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-18
Closed -$1.4K – 460
2025
Q3 		$1.4K Sell
18
-2
-10% -$156 ﹤0.01% 413
2025
Q2 		$1.56K Hold
20
– – ﹤0.01% 415
2025
Q1 		$1.45K Buy
+20
New +$1.43K ﹤0.01% 422

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

MJT & Associates Financial Advisory's EW Position: Q4 2025 in Review

MJT & Associates Financial Advisory sold out of Edwards Lifesciences (EW) in Q4 2025, closing a stake of 18 shares — an estimated $1.4K sold.

MJT & Associates Financial Advisory first reported a position in EW in Q1 2025 and held it in 3 quarters. The position peaked at $1.56K in Q2 2025. 1,315 funds tracked by Wall St. Rank hold EW as of Q4 2025.

  • MJT & Associates Financial Advisory reported no remaining Edwards Lifesciences position as of Q4 2025 after selling out during the quarter.
  • MJT & Associates Financial Advisory sold 18 Edwards Lifesciences shares in Q4 2025, an estimated $1.4K.
  • MJT & Associates Financial Advisory first reported a position in Edwards Lifesciences in Q1 2025 and held it in 3 quarters.
  • MJT & Associates Financial Advisory's Edwards Lifesciences position peaked at $1.56K in Q2 2025.
  • 1,315 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2025.

Based on MJT & Associates Financial Advisory's 13F filing for Q4 2025, filed 10 Feb 2026.